NASDAQ:UTMD Utah Medical Products (UTMD) Stock Price, News & Analysis $74.13 0.00 (0.00%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$74.28 +0.16 (+0.21%) As of 10/2/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsNews and TrendsOwnershipSEC FilingsShort Interest About Utah Medical Products Stock (NASDAQ:UTMD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Utah Medical Products alerts:Sign Up Key Stats Today's Range$74.13▼$74.4350-Day Range$69.10▼$76.6652-Week Range$53.66▼$76.89Volume19,638 shsAverage Volume31,442 shsMarket Capitalization$235.73 millionP/E Ratio22.60Dividend Yield1.67%Price TargetN/AConsensus RatingHold Company Overview Utah Medical Products, Inc. (NASDAQ: UTMD) develops, manufactures and markets disposable medical devices used in hospital and clinical settings. The company focuses primarily on products for obstetrics, gynecology, neonatal care, electrosurgery and related surgical procedures. Its product portfolio includes fetal monitoring electrodes and catheters, intrauterine pressure catheters, uterine manipulators, cervical dilators, neonatal respiratory products, electrosurgical instruments, grounding pads, biopsy devices and other specialized disposable instruments. These products are designed for use by physicians, nurses and other healthcare professionals. Founded in 1978 and headquartered in Midvale, Utah, Utah Medical Products serves customers in the United States and international markets. The company sells its products through direct sales and distributors, with international operations and distribution supporting customers in regions including Europe and other global markets.AI Generated. May Contain Errors. Read More Utah Medical Products Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScoreUTMD MarketRank™: Utah Medical Products scored higher than 19% of companies evaluated by MarketBeat, and ranked 805th out of 887 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingUtah Medical Products has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageUtah Medical Products has only been the subject of 1 research reports in the past 90 days.Read more about Utah Medical Products' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Utah Medical Products is 22.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.66.Price to Earnings Ratio vs. SectorThe P/E ratio of Utah Medical Products is 22.60, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.69.Price to Book Value per Share RatioUtah Medical Products has a P/B Ratio of 1.99. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Utah Medical Products' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.88% of the float of Utah Medical Products has been sold short.Short Interest Ratio / Days to CoverUtah Medical Products has a short interest ratio ("days to cover") of 4.53.Change versus previous monthShort interest in Utah Medical Products has recently increased by 3.22%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldUtah Medical Products pays a meaningful dividend of 1.67%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthUtah Medical Products has only been increasing its dividend for 3 years.Dividend CoverageThe dividend payout ratio of Utah Medical Products is 37.80%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Utah Medical Products' dividend. News and Social MediaN/ANews SentimentN/A Company Ownership1.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Utah Medical Products insiders have not sold or bought any company stock.Percentage Held by Insiders8.00% of the stock of Utah Medical Products is held by insiders.Percentage Held by Institutions69.60% of the stock of Utah Medical Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Utah Medical Products' insider trading history. Receive UTMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. UTMD Stock News HeadlinesUtah Medical Products, Inc. (NasdaqGS:UTMD) kündigt Aktienrückkauf über 650.000 Aktien an, entsprechend 20,48 % für 48,75 Mio. USDSeptember 25, 2026 | de.marketscreener.comDUtah Medical Launches Tender OfferSeptember 24, 2026 | finance.yahoo.comMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation. | Paradigm Press (Ad)Utah Medical Products Inc's Dividend AnalysisSeptember 17, 2026 | finance.yahoo.comUtah Medical Products, Inc.: UTMD Announces Self-Tender for 20% of Its SharesSeptember 15, 2026 | finanznachrichten.deUtah Medical Products' Femcare Buys UK-Based Orion Medical Supplies for $4.9 MillionSeptember 1, 2026 | finance.yahoo.comUtah Medical Products Expands Via Orion Medical AcquisitionAugust 31, 2026 | tipranks.comUtah Medical Products, Inc.: Femcare Ltd Acquires Orion Medical Supplies Ltd in the UKAugust 31, 2026 | finanznachrichten.deSee More Headlines UTMD Stock Analysis - Frequently Asked Questions How have UTMD shares performed this year? Utah Medical Products' stock was trading at $55.96 at the start of the year. Since then, UTMD shares have increased by 32.5% and is now trading at $74.13. How were Utah Medical Products' earnings last quarter? Utah Medical Products, Inc. (NASDAQ:UTMD) posted its quarterly earnings data on Thursday, July, 23rd. The medical instruments supplier reported $0.84 EPS for the quarter. The medical instruments supplier had revenue of $8.53 million for the quarter. Utah Medical Products had a net margin of 29.04% and a trailing twelve-month return on equity of 8.74%. How do I buy shares of Utah Medical Products? Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Utah Medical Products own? Based on aggregate information from My MarketBeat watchlists, some other companies that Utah Medical Products investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and AUO (AUOTY). Company Calendar Last Earnings7/23/2026Record date for 10/5 Dividend9/17/2026Ex-Dividend for 10/5 Dividend9/17/2026Today10/04/2026Dividend Payable10/05/2026Next Earnings (Estimated)10/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 UTMD's financial health is in the Green zone, according to TradeSmith. UTMD has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Supplies Current SymbolNASDAQ:UTMD CIK706698 Webwww.utahmed.com Phone(801) 566-1200Fax801-566-7305Employees152Year Founded1978Profitability EPS (Trailing Twelve Months)$3.28 Trailing P/E Ratio22.60 Forward P/E RatioN/A P/E GrowthN/ANet Income$11.29 million Net Margins29.04% Pretax Margin35.68% Return on Equity8.74% Return on Assets8.50% Debt Debt-to-Equity RatioN/A Current Ratio48.62 Quick Ratio44.27 Sales & Book Value Annual Sales$38.52 million Price / Sales6.12 Cash Flow$4.46 per share Price / Cash Flow16.61 Book Value$37.23 per share Price / Book1.99Miscellaneous Outstanding Shares3,180,000Free Float2,929,000Market Cap$235.73 million OptionableNot Optionable Beta0.38 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:UTMD) was last updated on 10/5/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Utah Medical Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Utah Medical Products With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
